Home/Filings/4/0001104659-23-091331
4//SEC Filing

Kim Hyung Heon 4

Accession 0001104659-23-091331

CIK 0001638287other

Filed

Aug 13, 8:00 PM ET

Accepted

Aug 14, 4:10 PM ET

Size

11.6 KB

Accession

0001104659-23-091331

Insider Transaction Report

Form 4
Period: 2023-08-11
Kim Hyung Heon
DirectorCEO & President
Transactions
  • Award

    Common Stock

    2023-08-11+625,064625,064 total
Footnotes (2)
  • [F1]Represents a grant of restricted stock units ("RSUs") issued to the reporting person under the Issuer's 2022 Equity Incentive Plan.
  • [F2]50% of the RSUs will vest on August 11, 2024, and the remainder will vest in equal monthly installments on the last day of each full month over the subsequent 12 months, subject to continuing service.

Issuer

NeuroBo Pharmaceuticals, Inc.

CIK 0001638287

Entity typeother

Related Parties

1
  • filerCIK 0001873258

Filing Metadata

Form type
4
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 4:10 PM ET
Size
11.6 KB